Loading company financials…
NASDAQ NMS - GLOBAL MARKET · Semiconductors · CIK 0001736297
$257.82
-11.11% · delayed ~15 min
Last price from Oct 22, 2026
$43.88B market value
From Astera Labs, Inc.'s FY2025 10-K, filed Feb 20, 2026 · read the filing
Astera Labs designs and makes computer chips. It took in $852.5M last year, which makes it a smaller company. Of every dollar it sells, about 26 cents is left as profit.
The financial picture is led by profitability, growth and debt.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Recent open-market selling by 3 insiders, not under a pre-arranged plan.
$64.0M sold in the last 120 days · Read the filing
These are things the company filed or that a published model flagged — not predictions, and not a reason on their own to buy or sell anything.
Financial health
Strong finances across the board.
From Astera Labs, Inc.'s FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Revenue
$396.3M → $852.5M
Gross profit
$302.7M → $645.3M
Operating income
-$116.1M → $173.4M
Profit
-$83.4M → $219.1M
Measured against FY2024, from the 10-K filed Feb 20, 2026
Improved: +115.1%
$396.3M to $852.5MCritical
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
How the latest move compares (quote delayed ~15 min), and what was published around it
ALAB fell 11.11% on the latest quote. The average Technology company tracked here moved −1.27%, and the S&P 500 −1.04%. That is 9.8 points below its sector and 10.1 points below the market.
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
The growth rate someone buying today is paying for, against what the company has delivered
At today's price, the market is paying for free cash flow to grow by about 33% a year for the next 10 years. Its free cash flow was negative earlier in this period, so there is no past growth rate to set against that.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 26 cents of every dollar of sales as profit, earning $219.1M last year.
Yes, quickly. Sales grew 115.1% last year.
It does not appear so. For every $1 it owes, it owns $9.11 in assets.
Core operating and valuation reference metrics
Income
This company pays no dividend. It keeps its profits and reinvests them in the business instead, so any return would have to come from the share price.
Figures from the FY2025 annual filing
Last year it earned $219.1M and generated $319.3M of cash from operations.
Reported annual figures
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Feb 20, 2026Filing for FY2025 | FY202410-K · Feb 14, 2025Filing for FY2024 | FY202310-K · Feb 14, 2025Filing for FY2023 | FY202210-K · Feb 14, 2025Filing for FY2022 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|
| RevenueWhat is this? | $852.5M | $396.3M | $115.8M | $79.9M | +115.1% |
| Cost of revenue | $207.3M | $93.6M | $36.0M | $21.2M | +121.5% |
| Gross profit | $645.3M | $302.7M | $79.8M | $58.7M | +113.2% |
| Gross marginGross profit ÷ revenueWhat is this? | 75.7% | 76.4% | 68.9% | 73.5% | −0.7 pts |
| Selling, general and administrative | $88.1M | $94.3M | $15.9M | $20.8M | −6.6% |
| Operating income | $173.4M | -$116.1M | -$29.5M | -$60.2M | n/m |
| Operating marginOperating income ÷ revenueWhat is this? | 20.3% | -29.3% | -25.5% | -75.4% | +49.6 pts |
| Income before tax | $218.2M | -$81.8M | -$22.9M | -$57.6M | n/m |
| Net income | $219.1M | -$83.4M | -$26.3M | -$58.3M | n/m |
| Net marginNet income ÷ revenueWhat is this? | 25.7% | -21.1% | -22.7% | -73.0% | +46.8 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $1.29 | $-0.5149 | $-0.6245 | $-1.71 | n/m |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| ALABAstera Labs, Inc. · this page | 10.0/10 | 5/8 |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Was granted or awarded shares — 68 shares at $311.57 ($21.2K)
Holds 50,524 shares after this filing.
Sold on the open market — 3,505 shares at $376.06 ($1.3M)
Holds 47,019 shares after this filing.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Quarterly report for Q2 FY2026
Revenue +104.5% · Operating margin +2.0 pts · Gross profit +97.6% — against Q2 FY2025
Read the filingPublished results
Read the filingWrite down why you are following Astera Labs, Inc., what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
Coverage from the last 30 days
Astera Labs Gains Ahead of Q3 as Scorpio Switches Set Up a 40% Sequential Jump
Yahoo ·
What Has The Market Missed In Credo Technology Stock's Drop?
Yahoo ·
Astera Labs, Inc. (ALAB) Outpaces Stock Market Gains: What You Should Know
Yahoo ·
Astera Labs (ALAB): Is the AI-Connectivity Competitor Ready for the S&P 500?
Yahoo ·
Astera Labs Lost 11% in a Week. Stifel Sees 60% Upside From Here
Yahoo ·
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from ALAB's 10-K for fiscal year 2025 (period ending 2025-12-31, filed Feb 20, 2026), reported under the US GAAP taxonomy. View the source filing.
3 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. Accounting had too few reported figures and is left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 8 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 10.0 | 5/8 | 10-K, filed Feb 20, 2026 |
| FY2024 | 7.3 | 4/8 | 10-K, filed Feb 14, 2025 |
| FY2023 | 4.7 | 1/5 | 10-K, filed Feb 14, 2025 |
| FY2022 | 2.0 | 1/2 | 10-K, filed Feb 14, 2025 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
5 of 8 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. One could not be evaluated and is excluded from the total rather than counted as a failure.
158.43
In the safe zone
For this model, above 2.99 is safe and below 1.81 is distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — This company has not reported enough of the required figures to calculate this score.
This company has not reported enough of the required figures to calculate this score.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Improved: +113.2%
$302.7M to $645.3MCritical
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Improved: turned positive
-$116.1M to $173.4MCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: turned positive
-$83.4M to $219.1MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +49.6 pts
-29.3% to 20.3%Critical
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Improved: +46.8 pts
-21.1% to 25.7%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: +175.1%
$102.4M to $281.8MCritical
Why it matters: Cash left after paying for the plant that produced it — the money genuinely available for dividends, buybacks or paying down debt. Harder to flatter than profit.
Improved: turned positive
-$0.51 to $1.29Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +110.7%
$79.6M to $167.6MCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Deteriorated: +5.0%
162.0M to 170.2MSignificant
Why it matters: New shares divide the same company into more pieces, so each existing holding owns slightly less of it. Often pay for staff or an acquisition rather than anything wrong.
Changed: +9.6%
$34.2M to $37.5MNotable
Why it matters: Neither good nor bad on its own. Heavy spending is a company building capacity or a company struggling to stand still, and the two look identical in this figure.
Q2 FY2026 against Q2 FY2025, from the 10-Q filed Aug 5, 2026 — read it.
Improved: +104.5%
$191.9M to $392.4MCritical
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Improved: +97.6%
$145.6M to $287.6MCritical
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Improved: +124.4%
$39.8M to $89.2MCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: +198.9%
$51.2M to $153.1MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +12.3 pts
26.7% to 39.0%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: +186.4%
$0.31 to $0.88Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: -31.3%
$162.3M to $111.5MSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Deteriorated: −2.6 pts
75.8% to 73.3%Notable
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
Improved: +2.0 pts
20.7% to 22.7%Notable
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Deteriorated: +4.4%
166.2M to 173.5MNotable
Why it matters: New shares divide the same company into more pieces, so each existing holding owns slightly less of it. Often pay for staff or an acquisition rather than anything wrong.
Q2 FY2026 against Q1 FY2026, from the 10-Q filed Aug 5, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Improved: +44.3%
$61.8M to $89.2MCritical
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: +90.6%
$80.3M to $153.1MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +13.0 pts
26.0% to 39.0%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: +88.2%
$0.47 to $0.88Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +27.3%
$308.4M to $392.4MSignificant
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Improved: +22.3%
$235.1M to $287.6MSignificant
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Deteriorated: -24.8%
$148.3M to $111.5MSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Deteriorated: −3.0 pts
76.3% to 73.3%Notable
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
Improved: +2.7 pts
20.1% to 22.7%Notable
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Deteriorated: +1.3%
171.3M to 173.5MNotable
Why it matters: New shares divide the same company into more pieces, so each existing holding owns slightly less of it. Often pay for staff or an acquisition rather than anything wrong.
1 other measure barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Discounted at 8%–10% a year, with growth settling to 2.5% after 10 years. Those rates are ordinary choices, not measurements: across that range the assumed growth works out between 30% and 36%. This describes what the price implies — it is not a forecast, and not a view on whether the price is right.
Opinions from 29 analysts covering this company, as of . Their views, not this site's.
Of 29 analysts publishing on this company, 7 say strong buy, 14 say buy and 8 say hold. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 5.4% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 116.8x — a high multiple relative to the current trailing profit.
This company has not reported enough of the required figures to calculate this score.
| 115.1% |
| 25.7% |
| 200.23x |
| 0.12x |
| ADIANALOG DEVICES INC | 10.0/10 | 8/9 | 16.9% | 20.6% | 83.31x | 0.42x |
|---|
| QCOMQUALCOMM INC/DE | 9.0/10 | 6/9 | 13.7% | 12.5% | 33.50x | 1.36x |
|---|
| MPWRMONOLITHIC POWER SYSTEMS, INC. | 10.0/10 | 6/8 | 26.4% | 22.3% | 91.54x | 0.19x |
|---|
| MCHPMICROCHIP TECHNOLOGY INC | 7.0/10 | 7/9 | 7.1% | 4.9% | 175.63x | 1.23x |
|---|
| ONON SEMICONDUCTOR CORP | 6.0/10 | 4/9 | -15.3% | 2.0% | 240.11x | 0.63x |
|---|
| Median of peers | 9.0/10 | — | 13.7% | 12.5% | 91.54x | 0.63x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Sold on the open market — 8,333 shares at $376.06 ($3.1M)
Holds 286,400 shares after this filing.
Sold on the open market — 661 shares at $376.06 ($248.6K)
Holds 2,648 shares after this filing.
Was granted or awarded shares — 72 shares at $311.57 ($22.4K)
Holds 92,554 shares after this filing.
Was granted or awarded shares — 68 shares at $311.57 ($21.2K)
Holds 6,893 shares after this filing.
Sold on the open market — 2,575 shares at $277.32 ($714.1K)
Holds 1,271,923 shares after this filing.
Sold on the open market — 20,991 shares at $278.33 ($5.8M)
Holds 1,250,932 shares after this filing.
Sold on the open market — 37,176 shares at $279.28 ($10.4M)
Holds 1,213,756 shares after this filing.
Sold on the open market — 59,379 shares at $280.04 ($16.6M)
Holds 1,154,377 shares after this filing.
Sold on the open market — 12,882 shares at $281.16 ($3.6M)
Holds 1,141,495 shares after this filing.
Sold on the open market — 5,870 shares at $282.13 ($1.7M)
Holds 1,135,625 shares after this filing.
Sold on the open market — 3,954 shares at $283.19 ($1.1M)
Holds 1,131,671 shares after this filing.
Sold on the open market — 2,245 shares at $284.17 ($638.0K)
Holds 1,129,426 shares after this filing.
Sold on the open market — 340 shares at $285.18 ($97.0K)
Holds 1,129,086 shares after this filing.
Sold on the open market — 2,677 shares at $286.99 ($768.3K)
Holds 1,126,409 shares after this filing.
Sold on the open market — 1,019 shares at $287.93 ($293.4K)
Holds 1,125,390 shares after this filing.
Sold on the open market — 892 shares at $288.95 ($257.7K)
Holds 1,124,498 shares after this filing.
Sold on the open market — 568 shares at $277.32 ($157.5K)
Holds 286,295 shares after this filing.
Sold on the open market — 4,618 shares at $278.33 ($1.3M)
Holds 281,677 shares after this filing.
Sold on the open market — 8,179 shares at $279.28 ($2.3M)
Holds 273,498 shares after this filing.
Sold on the open market — 13,070 shares at $280.04 ($3.7M)
Holds 260,428 shares after this filing.
Sold on the open market — 2,835 shares at $281.16 ($797.1K)
Holds 257,593 shares after this filing.
Sold on the open market — 1,288 shares at $282.13 ($363.4K)
Holds 256,305 shares after this filing.
Sold on the open market — 868 shares at $283.18 ($245.8K)
Holds 255,437 shares after this filing.
Sold on the open market — 491 shares at $284.18 ($139.5K)
Holds 254,946 shares after this filing.
Sold on the open market — 74 shares at $285.18 ($21.1K)
Holds 254,872 shares after this filing.
Sold on the open market — 588 shares at $287.00 ($168.8K)
Holds 254,284 shares after this filing.
Sold on the open market — 225 shares at $287.93 ($64.8K)
Holds 254,059 shares after this filing.
Sold on the open market — 196 shares at $288.95 ($56.6K)
Holds 253,863 shares after this filing.
Sold on the open market — 273 shares at $273.64 ($74.7K)
Holds 53,688 shares after this filing.
Sold on the open market — 650 shares at $273.64 ($177.9K)
Holds 302,416 shares after this filing.
Sold on the open market — 52 shares at $273.64 ($14.2K)
Holds 3,918 shares after this filing.
Sold on the open market — 2,275 shares at $274.79 ($625.1K)
Holds 51,413 shares after this filing.
Sold on the open market — 5,409 shares at $274.79 ($1.5M)
Holds 297,007 shares after this filing.
Sold on the open market — 429 shares at $274.79 ($117.9K)
Holds 3,489 shares after this filing.
Sold on the open market — 785 shares at $275.53 ($216.3K)
Holds 50,628 shares after this filing.
Sold on the open market — 1,867 shares at $275.53 ($514.4K)
Holds 295,140 shares after this filing.
Sold on the open market — 148 shares at $275.53 ($40.8K)
Holds 3,341 shares after this filing.
Sold on the open market — 172 shares at $276.75 ($47.6K)
Holds 50,456 shares after this filing.
Sold on the open market — 407 shares at $276.75 ($112.6K)
Holds 294,733 shares after this filing.
Sold on the open market — 32 shares at $276.75 ($8.9K)
Holds 3,309 shares after this filing.
Sold on the open market — 578 shares at $352.11 ($203.5K)
Holds 1,356,717 shares after this filing.
Sold on the open market — 1,049 shares at $351.24 ($368.5K)
Holds 1,355,668 shares after this filing.
Sold on the open market — 1,984 shares at $349.19 ($692.8K)
Holds 1,353,684 shares after this filing.
Sold on the open market — 1,057 shares at $348.05 ($367.9K)
Holds 1,352,627 shares after this filing.
Sold on the open market — 3,500 shares at $347.01 ($1.2M)
Holds 1,349,127 shares after this filing.
Sold on the open market — 2,525 shares at $346.13 ($874.0K)
Holds 1,346,602 shares after this filing.
Sold on the open market — 17,373 shares at $344.99 ($6.0M)
Holds 1,329,229 shares after this filing.
Sold on the open market — 3,713 shares at $343.94 ($1.3M)
Holds 1,325,516 shares after this filing.
Sold on the open market — 5,449 shares at $342.95 ($1.9M)
Holds 1,320,067 shares after this filing.
Sold on the open market — 1,610 shares at $341.71 ($550.1K)
Holds 1,318,457 shares after this filing.
Sold on the open market — 2,616 shares at $340.58 ($891.0K)
Holds 1,315,841 shares after this filing.
Sold on the open market — 6,484 shares at $339.74 ($2.2M)
Holds 1,309,357 shares after this filing.
Sold on the open market — 7,992 shares at $338.58 ($2.7M)
Holds 1,301,365 shares after this filing.
Sold on the open market — 10,438 shares at $337.76 ($3.5M)
Holds 1,290,927 shares after this filing.
Sold on the open market — 2,946 shares at $336.65 ($991.8K)
Holds 1,287,981 shares after this filing.
Sold on the open market — 1,782 shares at $335.41 ($597.7K)
Holds 1,286,199 shares after this filing.
Sold on the open market — 6,926 shares at $334.23 ($2.3M)
Holds 1,279,273 shares after this filing.
Sold on the open market — 12,608 shares at $333.60 ($4.2M)
Holds 1,266,665 shares after this filing.
Sold on the open market — 44 shares at $352.10 ($15.5K)
Holds 103,299 shares after this filing.
Sold on the open market — 82 shares at $351.24 ($28.8K)
Holds 103,217 shares after this filing.
Sold on the open market — 156 shares at $349.19 ($54.5K)
Holds 103,061 shares after this filing.
Sold on the open market — 81 shares at $348.05 ($28.2K)
Holds 102,980 shares after this filing.
Sold on the open market — 269 shares at $347.02 ($93.3K)
Holds 102,711 shares after this filing.
Sold on the open market — 199 shares at $346.13 ($68.9K)
Holds 102,512 shares after this filing.
Sold on the open market — 1,310 shares at $344.99 ($451.9K)
Holds 101,202 shares after this filing.
Sold on the open market — 287 shares at $343.94 ($98.7K)
Holds 100,915 shares after this filing.
Sold on the open market — 415 shares at $342.95 ($142.3K)
Holds 100,500 shares after this filing.
Sold on the open market — 125 shares at $341.71 ($42.7K)
Holds 100,375 shares after this filing.
Sold on the open market — 205 shares at $340.58 ($69.8K)
Holds 100,170 shares after this filing.
Sold on the open market — 504 shares at $339.74 ($171.2K)
Holds 99,666 shares after this filing.
Sold on the open market — 610 shares at $338.58 ($206.5K)
Holds 99,056 shares after this filing.
Sold on the open market — 797 shares at $337.76 ($269.2K)
Holds 98,259 shares after this filing.
Sold on the open market — 227 shares at $336.65 ($76.4K)
Holds 98,032 shares after this filing.
Sold on the open market — 136 shares at $335.42 ($45.6K)
Holds 97,896 shares after this filing.
Sold on the open market — 540 shares at $334.23 ($180.5K)
Holds 97,356 shares after this filing.
Sold on the open market — 814 shares at $333.64 ($271.6K)
Holds 96,542 shares after this filing.
Sold on the open market — 578 shares at $352.11 ($203.5K)
Holds 1,209,090 shares after this filing.
Sold on the open market — 1,049 shares at $351.24 ($368.5K)
Holds 1,208,041 shares after this filing.
Sold on the open market — 1,984 shares at $349.19 ($692.8K)
Holds 1,206,057 shares after this filing.
Sold on the open market — 1,057 shares at $348.05 ($367.9K)
Holds 1,205,000 shares after this filing.
Sold on the open market — 3,500 shares at $347.01 ($1.2M)
Holds 1,201,500 shares after this filing.
Sold on the open market — 2,525 shares at $346.13 ($874.0K)
Holds 1,198,975 shares after this filing.
Sold on the open market — 17,373 shares at $344.99 ($6.0M)
Holds 1,181,602 shares after this filing.
Sold on the open market — 3,713 shares at $343.94 ($1.3M)
Holds 1,177,889 shares after this filing.
Sold on the open market — 5,449 shares at $342.95 ($1.9M)
Holds 1,172,440 shares after this filing.
Sold on the open market — 1,610 shares at $341.71 ($550.1K)
Holds 1,170,830 shares after this filing.
Sold on the open market — 2,616 shares at $340.58 ($891.0K)
Holds 1,168,214 shares after this filing.
Sold on the open market — 6,484 shares at $339.74 ($2.2M)
Holds 1,161,730 shares after this filing.
Sold on the open market — 7,992 shares at $338.58 ($2.7M)
Holds 1,153,738 shares after this filing.
Sold on the open market — 10,438 shares at $337.76 ($3.5M)
Holds 1,143,300 shares after this filing.
Sold on the open market — 2,946 shares at $336.65 ($991.8K)
Holds 1,140,354 shares after this filing.
Sold on the open market — 1,782 shares at $335.41 ($597.7K)
Holds 1,138,572 shares after this filing.
Sold on the open market — 6,926 shares at $334.23 ($2.3M)
Holds 1,131,646 shares after this filing.
Sold on the open market — 12,608 shares at $333.60 ($4.2M)
Holds 1,119,038 shares after this filing.
Notice filed ahead of a planned sale — the sale itself has not necessarily happened yet.
Filed notice to sell 12,499 shares ($4.7M) on or after .
Shares originally obtained via Pro-rata distribution from Venture Fund.
Filed notice to sell 12,499 shares ($3.4M) on or after .
Shares originally obtained via Pro-rata distribution from Venture fund.
Filed notice to sell 33,000 shares ($9.8M) on or after .
Shares originally obtained via Private Acquisition from Issuer or an Affiliate.
Filed notice to sell 150,000 shares ($44.5M) on or after .
Shares originally obtained via Private Acquisition from Issuer or an Affiliate.
Filed notice to sell 170,000 shares ($50.5M) on or after .
Shares originally obtained via Private Acquisition from Issuer or an Affiliate.
Filed notice to sell 12,499 shares ($3.9M) on or after .
Shares originally obtained via Pro-rata distribution from Venture Fund.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Held a shareholder vote
Quarterly report for Q1 FY2026
Revenue +93.4% · Operating margin +13.0 pts · Gross profit +96.9% — against Q1 FY2025
Read the filingPublished results
Read the filingProxy statement for a shareholder meeting
Read the filingAnnual report for FY2025
Revenue +115.1% · Operating margin +49.6 pts · Gross profit +113.2% — against FY2024
Read the filingHad a director or senior officer leave or join
Read the filingPublished results
Read the filingSigned a material agreement · Sold shares outside a public offering
Read the filingHad a director or senior officer leave or join
Read the filingQuarterly report for Q3 FY2025
Revenue +103.9% · Operating margin +31.9 pts · Gross profit +100.1% — against Q3 FY2024
Read the filingPublished results
Read the filingReported another event
Read the filingQuarterly report for Q2 FY2025
Revenue +149.7% · Operating margin +52.4 pts · Gross profit +143.2% — against Q2 FY2024
Read the filingPublished results
Read the filingHeld a shareholder vote
Read the filingQuarterly report for Q1 FY2025
Revenue +144.3% · Operating margin +134.2 pts · Gross profit +136.4% — against Q1 FY2024
Read the filingPublished results
Read the filingProxy statement for a shareholder meeting
Read the filingPrimary sources and further research